-
If PROs were a drug, the public would demand immediate implementation! The case for PROs reducing costs and variations in care Prof Afaf Girgis
-
Cancer and Equality- The Global view Lena Sharp
-
How can mobilization of health data and application of AI inform decision making in cancer care Prof Tim Shaw
-
Latest developments in prostate cancer surgery and active surveillance Prof Stacy Loeb
-
Cancer Care 2040 – meeting the global demand Michael Barton
-
Overlooked minorities the intersection of cancer in lesbian, gay, bisexual, transgender andor intersex (LGBTI) adolescents and young adults Mairghread Clarke
-
Issues and limitations that arise with digital health Prof Trish Williams
-
Older cancer patients - the evolution of geriatric oncology AND palliative care Prof Jane Phillips
-
Risk-stratified melanoma prevention and screening Assoc Prof Anne E Cust
-
It’s not all face to face digital delivery of exercise oncology Michael Marthick
-
Personalising cancer prevention and screening Panel Anne E Cust, Michael O'Callaghan, Sanchia Aranda, Jonathan Karnon
-
My Health Record and beyond Harnessing the modern information revolution Angela Ryan
-
Renal function estimates vs measurements; implications for chemotherapy dosing Jenny Casanova
-
Metastatic hormone-sensitive prostate cancer A new era Assoc Prof Arun Azad
-
Challenges in demonstrating the value of cancer screening Prof Jonathan Karnon
-
Patient selection and dose prescription for radiation therapy Dr Marcus Dreosti
-
Prostate SBRT Is it ready for prime time George Hruby
-
How global health and oncology intersect Panel Michael Barton OAM, Lena Sharp, Hubertus Jersmann, Sanchia Aranda
